LEUCOSELECT
LIVE

Serial Number

79428150

Owner

INDENA S.p.A.

Attorney

John Alumit

Filing Date

May 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LEUCOSELECT Trademark

Serial Number: 79428150

LEUCOSELECT is a trademark filed by INDENA S.p.A. on May 29, 2025. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

INDENA S.p.A. (3 trademarks)

Viale Ortles, 12

Entity Type: 98

Trademark Details

Filing Date

May 29, 2025

Registration Date

Not Registered

Goods & Services

Herbal extracts, other than essential oils, for cosmetic purposes; cosmetic products

Active chemical ingredients for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemical additives for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemical substances for use in the manufacture of food ingredients for human and animal use; plant extracts, other than essential oils, for use in the manufacture of pharmaceuticals and dietary supplements; plant extracts, other than essential oils, for use in the manufacture of cosmetics

Pharmaceutical preparations for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases and chronic fatigue syndrome; pharmaceutical preparations and substances for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases and chronic fatigue syndrome; dietary supplements and dietetic preparations adapted for medical purposes for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases and chronic fatigue syndrome for human use; plant and herb extracts, other than essential oils, for medicinal and pharmaceutical use, and used as an integral component of dietary supplements for humans

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 21, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jul 21, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 21, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 21, 2026 CNEA
ASSIGNED TO EXAMINER
Jul 6, 2026 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2026 TROA
REFUSAL PROCESSED BY IB
Jan 1, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 14, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 17, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 16, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 16, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 18, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 17, 2025 REPR